scholarly article | Q13442814 |
P50 | author | Jinsong Bian | Q73151602 |
P2093 | author name string | Yong Yang | |
Lei Ding | |||
Xu Cao | |||
Matthew Whiteman | |||
Philip K Moore | |||
Zhi-Zhong Xie | |||
P2860 | cites work | Targeting aspartate aminotransferase in breast cancer | Q22000773 |
DNA Damage, Aging, and Cancer | Q22121931 | ||
Hallmarks of Cancer: The Next Generation | Q22252312 | ||
Human sulfide:quinone oxidoreductase catalyzes the first step in hydrogen sulfide metabolism and produces a sulfane sulfur metabolite | Q24294580 | ||
S-sulfhydration of MEK1 leads to PARP-1 activation and DNA damage repair | Q24296356 | ||
Hydrogen sulfide-linked sulfhydration of NF-κB mediates its antiapoptotic actions | Q24301813 | ||
Cell cycle, CDKs and cancer: a changing paradigm | Q24314465 | ||
Hydrogen sulfide and nitric oxide are mutually dependent in the regulation of angiogenesis and endothelium-dependent vasorelaxation | Q24597604 | ||
Understanding the Warburg effect: the metabolic requirements of cell proliferation | Q24604760 | ||
Dynamics of carbon monoxide binding to cystathionine beta-synthase | Q24652874 | ||
Mucosal protection against sulphide: importance of the enzyme rhodanese | Q24670188 | ||
Hydrogen sulfide mediates the vasoactivity of garlic | Q24673752 | ||
Hydrogen Sulfide and Cellular Redox Homeostasis | Q26765798 | ||
Interaction of Hydrogen Sulfide with Nitric Oxide in the Cardiovascular System | Q26774063 | ||
Emergence of hydrogen sulfide as an endogenous gaseous signaling molecule in cardiovascular disease | Q26823796 | ||
Hydrogen sulfide chemical biology: pathophysiological roles and detection | Q26824672 | ||
Anti-cancer activity of new designer hydrogen sulfide-donating hybrids | Q26825705 | ||
Structure and Kinetic Analysis of H2S Production by Human Mercaptopyruvate Sulfurtransferase | Q27678264 | ||
Relative contributions of cystathionine beta-synthase and gamma-cystathionase to H2S biogenesis via alternative trans-sulfuration reactions | Q27929768 | ||
The Role of Hydrogen Sulfide in Renal System | Q28066719 | ||
Aberrant rel/nfkb genes and activity in human cancer | Q28140722 | ||
Proliferation, cell cycle and apoptosis in cancer | Q28189476 | ||
Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation | Q28200154 | ||
Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects | Q28200181 | ||
The role of cystathionine beta-synthase in homocysteine metabolism | Q28250320 | ||
H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase | Q28298435 | ||
Hydrogen sulfide protects the retina from light-induced degeneration by the modulation of Ca2+ influx | Q35604374 | ||
Hydrogen Sulfide Donor GYY4137 Protects against Myocardial Fibrosis. | Q35640723 | ||
An Anticancer Role of Hydrogen Sulfide in Human Gastric Cancer Cells. | Q35640793 | ||
GYY4137 protects against myocardial ischemia and reperfusion injury by attenuating oxidative stress and apoptosis in rats | Q35666649 | ||
Hydrogen Sulfide Promotes Tet1- and Tet2-Mediated Foxp3 Demethylation to Drive Regulatory T Cell Differentiation and Maintain Immune Homeostasis | Q35746822 | ||
Hydrogen sulfide is an endogenous potentiator of T cell activation | Q35763228 | ||
Endogenous production of hydrogen sulfide in mammals | Q35819602 | ||
Hydrogen sulfide protects colon cancer cells from chemopreventative agent beta-phenylethyl isothiocyanate induced apoptosis | Q35851111 | ||
Hydrogen sulfide is a signaling molecule and a cytoprotectant | Q35929049 | ||
Hydrogen sulfide in biochemistry and medicine | Q35929408 | ||
Identification of Additional Anti-Persister Activity against Borrelia burgdorferi from an FDA Drug Library | Q35973174 | ||
Shared signaling pathways among gasotransmitters | Q36061562 | ||
NOSH-Aspirin: A Novel Nitric Oxide-Hydrogen Sulfide-Releasing Hybrid: A New Class of Anti-inflammatory Pharmaceuticals | Q36176425 | ||
Toxicology of Hydrogen Sulfide | Q36213459 | ||
Hydrogen Sulfide and Cancer | Q36336507 | ||
Hydrogen sulfide stimulates ischemic vascular remodeling through nitric oxide synthase and nitrite reduction activity regulating hypoxia-inducible factor-1α and vascular endothelial growth factor-dependent angiogenesis. | Q36522675 | ||
A novel persulfide detection method reveals protein persulfide- and polysulfide-reducing functions of thioredoxin and glutathione systems. | Q36532821 | ||
Heme oxygenase-1 in macrophages controls prostate cancer progression | Q36545252 | ||
Role of cystathionine beta synthase in lipid metabolism in ovarian cancer | Q36545745 | ||
Measurement of plasma hydrogen sulfide in vivo and in vitro | Q36702598 | ||
Improved tag-switch method reveals that thioredoxin acts as depersulfidase and controls the intracellular levels of protein persulfidation. | Q36837643 | ||
"Zipped Synthesis" by Cross-Metathesis Provides a Cystathionine β-Synthase Inhibitor that Attenuates Cellular H2S Levels and Reduces Neuronal Infarction in a Rat Ischemic Stroke Model | Q36850630 | ||
Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway. | Q36850905 | ||
Hypoxia: a key regulator of angiogenesis in cancer | Q36866153 | ||
Selectivity of commonly used pharmacological inhibitors for cystathionine β synthase (CBS) and cystathionine γ lyase (CSE). | Q36943270 | ||
Thrombospondin-1 is a CD47-dependent endogenous inhibitor of hydrogen sulfide signaling in T cell activation | Q36997217 | ||
A H 2 S Donor GYY4137 Exacerbates Cisplatin-Induced Nephrotoxicity in Mice. | Q37000218 | ||
Tumor-derived hydrogen sulfide, produced by cystathionine-β-synthase, stimulates bioenergetics, cell proliferation, and angiogenesis in colon cancer | Q37049363 | ||
Putative biological roles of hydrogen sulfide in health and disease: a breath of not so fresh air? | Q37052295 | ||
Oxygen-sensitive mitochondrial accumulation of cystathionine β-synthase mediated by Lon protease | Q37068583 | ||
Garlic oil polysulfides: H2S- and O2-independent prooxidants in buffer and antioxidants in cells | Q37071845 | ||
Cisplatin nephrotoxicity: mechanisms and renoprotective strategies | Q37084089 | ||
Interplay between heme oxygenase-1 and miR-378 affects non-small cell lung carcinoma growth, vascularization, and metastasis | Q37087420 | ||
The endogenous production of hydrogen sulphide in intrauterine tissues | Q37097518 | ||
Discovery and saturation analysis of cancer genes across 21 tumour types | Q28305204 | ||
High performance liquid chromatographic determination of bound sulfide and sulfite and thiosulfate at their low levels in human serum by pre-column fluorescence derivatization with monobromobimane | Q28317998 | ||
The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener | Q28363080 | ||
Cellular stress responses, the hormesis paradigm, and vitagenes: novel targets for therapeutic intervention in neurodegenerative disorders | Q28384232 | ||
Reactive oxygen species, cellular redox systems, and apoptosis | Q28393669 | ||
Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB | Q28508403 | ||
H2S signals through protein S-sulfhydration | Q28511531 | ||
3-Mercaptopyruvate sulfurtransferase produces hydrogen sulfide and bound sulfane sulfur in the brain | Q28513550 | ||
Cystathionine beta-synthase (CBS) contributes to advanced ovarian cancer progression and drug resistance | Q28535061 | ||
Tissue and subcellular distribution of mercaptopyruvate sulfurtransferase in the rat: confocal laser fluorescence and immunoelectron microscopic studies combined with biochemical analysis | Q28569061 | ||
Hydrogen sulfide protects neurons against hypoxic injury via stimulation of ATP-sensitive potassium channel/protein kinase C/extracellular signal-regulated kinase/heat shock protein 90 pathway | Q28572649 | ||
Hydrogen sulfide-mediated stimulation of mitochondrial electron transport involves inhibition of the mitochondrial phosphodiesterase 2A, elevation of cAMP and activation of protein kinase A | Q28574416 | ||
Cystathionine gamma-lyase overexpression inhibits cell proliferation via a H2S-dependent modulation of ERK1/2 phosphorylation and p21Cip/WAK-1 | Q28576810 | ||
Purification and characterization of cysteine aminotransferase from rat liver cytosol | Q28576872 | ||
S-Propargyl-cysteine, a novel hydrogen sulfide-modulated agent, attenuates lipopolysaccharide-induced spatial learning and memory impairment: Involvement of TNF signaling and NF-κB pathway in rats | Q28583198 | ||
Molecular mechanisms and clinical applications of angiogenesis | Q29547314 | ||
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis | Q29614217 | ||
Drug resistance and the solid tumor microenvironment | Q29614403 | ||
An essential role for NF-kappaB in preventing TNF-alpha-induced cell death | Q29614707 | ||
Cell cycle control and cancer | Q29617536 | ||
The impact of O2 availability on human cancer | Q29619884 | ||
Human polycomb 2 protein is a SUMO E3 ligase and alleviates substrate-induced inhibition of cystathionine beta-synthase sumoylation | Q30440592 | ||
H2S biogenesis by human cystathionine gamma-lyase leads to the novel sulfur metabolites lanthionine and homolanthionine and is responsive to the grade of hyperhomocysteinemia | Q30487095 | ||
Hydrogen sulfide is an endogenous stimulator of angiogenesis. | Q30492603 | ||
Redox biochemistry of hydrogen sulfide | Q30495475 | ||
Hydrogen sulfide (H2S) metabolism in mitochondria and its regulatory role in energy production | Q30505673 | ||
Key bioactive reaction products of the NO/H2S interaction are S/N-hybrid species, polysulfides, and nitroxyl. | Q30662956 | ||
Mutations in the regulatory domain of cystathionine beta synthase can functionally suppress patient-derived mutations in cis. | Q32069456 | ||
Nrf2: friend or foe for chemoprevention? | Q33575690 | ||
Hypoxic pulmonary vasodilation: a paradigm shift with a hydrogen sulfide mechanism | Q33589523 | ||
Reactive cysteine persulfides and S-polythiolation regulate oxidative stress and redox signaling | Q33694685 | ||
Novel insights into hydrogen sulfide--mediated cytoprotection. | Q33830124 | ||
Detoxification of hydrogen sulfide and methanethiol in the cecal mucosa | Q33859570 | ||
The effect of hydrogen sulfide donors on lipopolysaccharide-induced formation of inflammatory mediators in macrophages | Q33875055 | ||
Carbon monoxide: an emerging regulator of ion channels | Q33882424 | ||
Hydrogen sulfide acts as a double-edged sword in human hepatocellular carcinoma cells through EGFR/ERK/MMP-2 and PTEN/AKT signaling pathways | Q33895006 | ||
Hydrogen sulfide-releasing aspirin inhibits the growth of leukemic Jurkat cells and modulates β-catenin expression | Q37161280 | ||
Modulation of histone deacetylase activity by dietary isothiocyanates and allyl sulfides: studies with sulforaphane and garlic organosulfur compounds | Q37240767 | ||
A novel hydrogen sulfide prodrug, SG1002, promotes hydrogen sulfide and nitric oxide bioavailability in heart failure patients | Q37279303 | ||
The inhibition of mitochondrial cytochrome oxidase by the gases carbon monoxide, nitric oxide, hydrogen cyanide and hydrogen sulfide: chemical mechanism and physiological significance | Q37288616 | ||
The complex effects of the slow-releasing hydrogen sulfide donor GYY4137 in a model of acute joint inflammation and in human cartilage cells. | Q37295023 | ||
Beyond DNA Repair: Additional Functions of PARP-1 in Cancer | Q37346306 | ||
Carbon monoxide expedites metabolic exhaustion to inhibit tumor growth | Q37365107 | ||
Novel dithiolethione-modified nonsteroidal anti-inflammatory drugs in human hepatoma HepG2 and colon LS180 cells. | Q37371516 | ||
No facilitator required for membrane transport of hydrogen sulfide | Q37377256 | ||
Modulation of the heme electronic structure and cystathionine beta-synthase activity by second coordination sphere ligands: The role of heme ligand switching in redox regulation. | Q37409372 | ||
Is hydrogen sulfide a circulating "gasotransmitter" in vertebrate blood? | Q37441330 | ||
Bench-to-bedside review: Hydrogen sulfide--the third gaseous transmitter: applications for critical care | Q37516593 | ||
Apoptosis and cancer: the genesis of a research field | Q37529250 | ||
5-FU targets rpL3 to induce mitochondrial apoptosis via cystathionine-β-synthase in colon cancer cells lacking p53. | Q37580393 | ||
Making and working with hydrogen sulfide: The chemistry and generation of hydrogen sulfide in vitro and its measurement in vivo: a review | Q37601063 | ||
Hydrogen sulfide: from brain to gut. | Q37608291 | ||
Gasotransmitters in cancer: from pathophysiology to experimental therapy | Q37656625 | ||
Regulation of cardiovascular cell function by hydrogen sulfide (H(2)S). | Q37682138 | ||
Regulation of mitochondrial bioenergetic function by hydrogen sulfide. Part I. Biochemical and physiological mechanisms | Q37686284 | ||
Catalase as a sulfide-sulfur oxido-reductase: An ancient (and modern?) regulator of reactive sulfur species (RSS). | Q37700190 | ||
Hydrogen sulfide: its production, release and functions | Q37700262 | ||
Enhancement of tumor cell death by combining cisplatin with an oncolytic adenovirus carrying MDA-7/IL-24 | Q37727955 | ||
Hydrogen sulfide and cell signaling. | Q37826422 | ||
Chemical properties and mechanisms determining the anti-cancer action of garlic-derived organic sulfur compounds. | Q37832516 | ||
Hydrogen sulfide gas has cell growth regulatory role | Q37837123 | ||
Hydrogen sulfide and inflammation: the good, the bad, the ugly and the promising | Q37960610 | ||
Hydrogen sulfide in the mammalian cardiovascular system. | Q37981269 | ||
Differentiating among incretin therapies: a multiple-target approach to type 2 diabetes | Q37995760 | ||
Combining immunotherapy and targeted therapies in cancer treatment | Q37995939 | ||
Physiological implications of hydrogen sulfide: a whiff exploration that blossomed | Q38005671 | ||
Biology and therapeutic potential of hydrogen sulfide and hydrogen sulfide-releasing chimeras | Q38056004 | ||
Regulation of mercaptopyruvate sulfurtransferase activity via intrasubunit and intersubunit redox-sensing switches | Q38059256 | ||
How cancer metabolism is tuned for proliferation and vulnerable to disruption | Q38059777 | ||
Prodrugs of nonsteroidal anti-inflammatory drugs (NSAIDs), more than meets the eye: a critical review | Q38068081 | ||
Chemical aspects of hydrogen sulfide measurements in physiological samples | Q38114680 | ||
Hydrogen sulfide-releasing aspirin suppresses NF-κB signaling in estrogen receptor negative breast cancer cells in vitro and in vivo | Q39419473 | ||
Hydrogen sulfide mediates the anti-survival effect of sulforaphane on human prostate cancer cells | Q39456872 | ||
Molecular basis underlying the biological effects elicited by extremely low-frequency magnetic field (ELF-MF) on neuroblastoma cells. | Q39492971 | ||
HNO suppresses LPS-induced inflammation in BV-2 microglial cells via inhibition of NF-κB and p38 MAPK pathways | Q39506027 | ||
Antitumoral activity of allicin in murine lymphoma L5178Y. | Q39613045 | ||
Allicin purified from fresh garlic cloves induces apoptosis in colon cancer cells via Nrf2. | Q39647808 | ||
Oxidation of hydrogen sulfide remains a priority in mammalian cells and causes reverse electron transfer in colonocytes. | Q39714012 | ||
Hydrogen sulfide induces human colon cancer cell proliferation: role of Akt, ERK and p21. | Q39735129 | ||
Growth of desulfovibrio in lactate or ethanol media low in sulfate in association with H2-utilizing methanogenic bacteria | Q39812639 | ||
GYY4137, a novel hydrogen sulfide-releasing molecule, protects against endotoxic shock in the rat. | Q39859585 | ||
1,4-Naphthoquinone is a potent inhibitor of human cancer cell growth and angiogenesis | Q39891048 | ||
Hydrogen sulfide induces direct radical-associated DNA damage. | Q40138015 | ||
Tangeretin and nobiletin induce G1 cell cycle arrest but not apoptosis in human breast and colon cancer cells | Q40188424 | ||
Hydrogen sulfide inhibits nitric oxide production and nuclear factor-kappaB via heme oxygenase-1 expression in RAW264.7 macrophages stimulated with lipopolysaccharide | Q40266368 | ||
L-cysteine inhibits insulin release from the pancreatic beta-cell: possible involvement of metabolic production of hydrogen sulfide, a novel gasotransmitter | Q40286540 | ||
Hydrogen sulphide: a novel inhibitor of hypochlorous acid-mediated oxidative damage in the brain? | Q40479415 | ||
The novel neuromodulator hydrogen sulfide: an endogenous peroxynitrite 'scavenger'? | Q40535164 | ||
Hydrogen sulfide induces serum-independent cell cycle entry in nontransformed rat intestinal epithelial cells. | Q40648929 | ||
Nephrotoxicity and hydration management for cisplatin, carboplatin, and ormaplatin | Q40848346 | ||
Cisplatin and DNA repair in cancer chemotherapy | Q40930064 | ||
Kinetic and thermodynamic studies on the disulfide-bond reducing potential of hydrogen sulfide | Q41685113 | ||
Detection of protein S-sulfhydration by a tag-switch technique. | Q41806978 | ||
A fluorescent probe for fast and quantitative detection of hydrogen sulfide in blood. | Q41885434 | ||
Detection of exhaled hydrogen sulphide gas in rats exposed to intravenous sodium sulphide | Q41990618 | ||
Hydrogen Sulfide Oxidation by Myoglobin. | Q42212484 | ||
A monobromobimane-based assay to measure the pharmacokinetic profile of reactive sulphide species in blood | Q42429578 | ||
A source of hydrogen sulfide and a mechanism of its release in the brain | Q42440890 | ||
The coordination of S-sulfhydration, S-nitrosylation, and phosphorylation of endothelial nitric oxide synthase by hydrogen sulfide | Q42465332 | ||
Stimulation of cystine uptake by nitric oxide: regulation of endothelial cell glutathione levels | Q42470465 | ||
S-Sulfhydration of ATP synthase by hydrogen sulfide stimulates mitochondrial bioenergetics | Q42498020 | ||
Carbon monoxide stimulates global protein methylation via its inhibitory action on cystathionine β-synthase. | Q42573621 | ||
Cisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effects | Q42575787 | ||
Rat cystathionine beta-synthase. Gene organization and alternative splicing | Q42611353 | ||
Endogenously produced hydrogen sulfide supports tumor cell growth and proliferation | Q42770490 | ||
Hypoxia-Inducible Factor-1.ALPHA. Is Involved in the Pro-angiogenic Effect of Hydrogen Sulfide under Hypoxic Stress | Q42914634 | ||
Hydrogen sulfide interacts with nitric oxide in the heart: possible involvement of nitroxyl | Q42957349 | ||
Hypoxia in the renal medulla: implications for hydrogen sulfide signaling. | Q43081728 | ||
Hydrogen sulfide ameliorates the kidney dysfunction and damage in cisplatin-induced nephrotoxicity in rat. | Q43085121 | ||
Modulation of thiol homeostasis induced by H2S-releasing aspirin | Q43156037 | ||
Hydrogen sulfide regulates intracellular pH in rat primary cultured glia cells | Q43264328 | ||
Role of cystathionine β-synthase in human breast Cancer | Q43800252 | ||
Exhaled hydrogen sulfide in patients with chronic obstructive pulmonary disease and its correlation with exhaled nitric oxide | Q43819468 | ||
Characterization of NO binding to human cystathionine beta-synthase: possible implications of the effects of CO and NO binding to the human enzyme | Q43823323 | ||
Rat cystathionine beta-synthase: expression of four alternatively spliced isoforms in transfected cultured cells | Q43914547 | ||
Polysulfides are possible H2S-derived signaling molecules in rat brain. | Q44122492 | ||
A novel pathway for the production of hydrogen sulfide from D-cysteine in mammalian cells | Q44131370 | ||
Comparative effects of mono-, di-, tri-, and tetrasulfides derived from plants of the Allium family: redox cycling in vitro and hemolytic activity and Phase 2 enzyme induction in vivo | Q44410814 | ||
Changes in arterial hydrogen sulfide (H(2)S) content during septic shock and endotoxin shock in rats | Q44512617 | ||
Modulation of endogenous production of H2S in rat tissues | Q44653708 | ||
H2S generated by heart in rat and its effects on cardiac function | Q44698472 | ||
Anti-inflammatory and gastrointestinal effects of a novel diclofenac derivative | Q44706021 | ||
Thiosulfate: a readily accessible source of hydrogen sulfide in oxygen sensing | Q44933023 | ||
H2S and NO cooperatively regulate vascular tone by activating a neuroendocrine HNO-TRPA1-CGRP signalling pathway | Q33924111 | ||
The slow-releasing hydrogen sulfide donor, GYY4137, exhibits novel anti-cancer effects in vitro and in vivo | Q33942063 | ||
Hydrogen sulfide represses androgen receptor transactivation by targeting at the second zinc finger module | Q33947136 | ||
H2S donor, S-propargyl-cysteine, increases CSE in SGC-7901 and cancer-induced mice: evidence for a novel anti-cancer effect of endogenous H2S? | Q33954567 | ||
The use of transformed IMR90 cell model to identify the potential extra-telomeric effects of hTERT in cell migration and DNA damage response | Q34021399 | ||
Sequence of cDNA for rat cystathionine gamma-lyase and comparison of deduced amino acid sequence with related Escherichia coli enzymes | Q34052124 | ||
Hypoxic regulation of the cerebral microcirculation is mediated by a carbon monoxide-sensitive hydrogen sulfide pathway. | Q34122686 | ||
Effect of S-adenosyl-L-methionine (SAM), an allosteric activator of cystathionine-β-synthase (CBS) on colorectal cancer cell proliferation and bioenergetics in vitro | Q34145385 | ||
Two's company, three's a crowd: can H2S be the third endogenous gaseous transmitter? | Q34157091 | ||
NOSH-aspirin (NBS-1120), a novel nitric oxide- and hydrogen sulfide-releasing hybrid is a potent inhibitor of colon cancer cell growth in vitro and in a xenograft mouse model | Q34256975 | ||
H₂S signalling through protein sulfhydration and beyond | Q34287129 | ||
Hydrogen sulfide lowers proliferation and induces protective autophagy in colon epithelial cells. | Q34297044 | ||
Sulfur amino acid metabolism: pathways for production and removal of homocysteine and cysteine | Q34326009 | ||
Protective effect of hydrogen sulphide against 6‐OHDA‐induced cell injury in SH‐SY5Y cells involves PKC/PI3K/Akt pathway | Q34339802 | ||
PI3K-Akt pathway: its functions and alterations in human cancer | Q34362034 | ||
Hydrogen sulfide cytoprotective signaling is endothelial nitric oxide synthase-nitric oxide dependent | Q34403540 | ||
NF-kappa B: a crucial transcription factor for glial and neuronal cell function | Q34428983 | ||
Organization of the human mitochondrial hydrogen sulfide oxidation pathway | Q34467414 | ||
Carbon monoxide: endogenous production, physiological functions, and pharmacological applications | Q34480319 | ||
Expression profile of hydrogen sulfide and its synthases correlates with tumor stage and grade in urothelial cell carcinoma of bladder | Q34512480 | ||
Utilizing hydrogen sulfide as a novel anti-cancer agent by targeting cancer glycolysis and pH imbalance | Q34559610 | ||
Nephrotoxicity induced by cancer chemotherapy with special emphasis on cisplatin toxicity | Q34690068 | ||
The association between the 844ins68 polymorphism in the CBS gene and breast cancer | Q34974355 | ||
Actions and interactions of nitric oxide, carbon monoxide and hydrogen sulphide in the cardiovascular system and in inflammation--a tale of three gases! | Q34984278 | ||
Vascular endothelium expresses 3-mercaptopyruvate sulfurtransferase and produces hydrogen sulfide. | Q34992435 | ||
S-glutathionylation enhances human cystathionine β-synthase activity under oxidative stress conditions. | Q35015674 | ||
The therapeutic potential of cystathionine β-synthetase/hydrogen sulfide inhibition in cancer | Q35016080 | ||
Role of hydrogen sulphide in haemorrhagic shock in the rat: protective effect of inhibitors of hydrogen sulphide biosynthesis | Q35048409 | ||
Hydrogen sulfide accelerates cell cycle progression in oral squamous cell carcinoma cell lines | Q35109557 | ||
Interactions of hydrogen sulfide with myeloperoxidase | Q35204852 | ||
Reversible heme-dependent regulation of human cystathionine β-synthase by a flavoprotein oxidoreductase. | Q35243063 | ||
Hydrogen sulphide and angiogenesis: mechanisms and applications. | Q35375963 | ||
Marine natural products as inhibitors of cystathionine beta-synthase activity | Q35558545 | ||
Sulfide, the first inorganic substrate for human cells | Q56611319 | ||
Evidence for the formation of a novel nitrosothiol from the gaseous mediators nitric oxide and hydrogen sulphide | Q57931896 | ||
Selective fluorescent probes for live-cell monitoring of sulphide | Q61198325 | ||
Extractive alkylation and gas chromatographic analysis of sulfide | Q68293344 | ||
Determination of sulfide in brain tissue and rumen fluid by ion-interaction reversed-phase high-performance liquid chromatography | Q68834764 | ||
Pharmacokinetics of cis-diamminedichloroplatinum(II) after administration in hypertonic saline | Q69614900 | ||
Monoamine oxidase inhibition as a sequel of hydrogen sulfide intoxication: increases in brain catecholamine and 5-hydroxytryptamine levels | Q69625532 | ||
Determination of sulfide in brain tissue by gas dialysis/ion chromatography: postmortem studies and two case reports | Q69631168 | ||
The oxidation of L- and D-cysteine to inorganic sulfate and taurine in the rat | Q70968282 | ||
Oxidation of sodium sulphide by rat liver, lungs and kidney | Q71350765 | ||
Thiol S-methyltransferase: suggested role in detoxication of intestinal hydrogen sulfide | Q71391175 | ||
Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix | Q71545581 | ||
Reactions catalysed by serine sulfhydrase from chicken liver | Q72360091 | ||
Monobromobimane: a substrate for the fluorimetric assay of glutathione transferase | Q72558041 | ||
Oxidation of hydrogen sulfide and methanethiol to thiosulfate by rat tissues: a specialized function of the colonic mucosa | Q73965302 | ||
Sulfur reduction by human erythrocytes | Q77356166 | ||
Cisplatin nephrotoxicity | Q78761584 | ||
Hydrogen sulfide mediates vasoactivity in an O2-dependent manner | Q79609011 | ||
Hydrogen sulphide regulates intracellular pH in vascular smooth muscle cells | Q80389174 | ||
The novel proangiogenic effect of hydrogen sulfide is dependent on Akt phosphorylation | Q80613445 | ||
Hydrogen sulfide enhances ulcer healing in rats | Q80624339 | ||
Reappraisal of H2S/sulfide concentration in vertebrate blood and its potential significance in ischemic preconditioning and vascular signaling | Q81098816 | ||
Polarographic measurement of hydrogen sulfide production and consumption by mammalian tissues | Q81706798 | ||
Reactivity of hydrogen sulfide with peroxynitrite and other oxidants of biological interest | Q82231964 | ||
Passive loss of hydrogen sulfide in biological experiments | Q82362478 | ||
Hydrogen sulfide as a new endogenous gaseous transmitter in the cardiovascular system | Q82528556 | ||
Polydimethylsiloxane permeability-based method for the continuous and specific detection of hydrogen sulfide | Q84334809 | ||
Hydrogen sulfide promotes calcium signals and migration in tumor-derived endothelial cells | Q84850837 | ||
Rapid reaction of hydrogen sulfide with the neutrophil oxidant hypochlorous acid to generate polysulfides | Q85038733 | ||
Hydrogen sulfide is produced by cystathionine γ-lyase at the steady-state low intracellular Ca(2+) concentrations | Q85892282 | ||
[Correlation of methylation of CpG island in cystathionine beta synthase promoter and clinicopathological features in colorectal cancer] | Q85959630 | ||
Identification of cystathionine β-synthase inhibitors using a hydrogen sulfide selective probe | Q86434332 | ||
Role of human sulfide: quinone oxidoreductase in H2S metabolism | Q86844399 | ||
The anti-thrombotic effect of hydrogen sulfide is partly mediated by an upregulation of nitric oxide synthases | Q87203045 | ||
Expression of cystathionine beta-synthase is downregulated in hepatocellular carcinoma and associated with poor prognosis | Q95822068 | ||
Thioredoxin and Cancer: A Role for Thioredoxin in all States of Tumor Oxygenation | Q38166568 | ||
Controversies and conundrums in hydrogen sulfide biology | Q38220160 | ||
Fluorescence chemosensors for hydrogen sulfide detection in biological systems | Q38295883 | ||
Study on the inhibitory effect of allicin on human gastric cancer cell line SGC-7901 and its mechanism | Q38312453 | ||
Mechanistic chemical perspective of hydrogen sulfide signaling. | Q38366069 | ||
Hydrogen sulfide-based therapeutics: exploiting a unique but ubiquitous gasotransmitter | Q38409371 | ||
Hydrogen sulfide in cancer: Friend or foe? | Q38571666 | ||
A critical review of the literature on hydrogen sulfide toxicity | Q38583535 | ||
CO-CBS-H2 S Axis: From Vascular Mediator to Cancer Regulator | Q38625414 | ||
Nitroxyl (HNO): A Possible Strategy for Fighting Cancer. | Q38731725 | ||
Hydrogen sulfide: A novel nephroprotectant against cisplatin-induced renal toxicity | Q38812510 | ||
A practical guide to working with H2S at the interface of chemistry and biology. | Q38831885 | ||
Nrf2-heme oxygenase-1 axis in mucoepidermoid carcinoma of the lung: Antitumoral effects associated with down-regulation of matrix metalloproteinases | Q38833582 | ||
Discovery of New H2S Releasing Phosphordithioates and 2,3-Dihydro-2-phenyl-2-sulfanylenebenzo[d][1,3,2]oxazaphospholes with Improved Antiproliferative Activity. | Q38856414 | ||
Garlic-derived natural polysulfanes as hydrogen sulfide donors: Friend or foe? | Q38901220 | ||
Role of the cystathionine γ lyase/hydrogen sulfide pathway in human melanoma progression. | Q38957953 | ||
Wnt/β-catenin signaling induces the transcription of cystathionine-γ-lyase, a stimulator of tumor in colon cancer | Q38959405 | ||
Major pathogenic mechanisms in vascular dementia: Roles of cellular stress response and hormesis in neuroprotection | Q38962899 | ||
Decreased expression of cystathionine β-synthase promotes glioma tumorigenesis | Q38978111 | ||
Hydrogen sulfide reduces RAGE toxicity through inhibition of its dimer formation | Q39009131 | ||
GYY4137, a hydrogen sulfide (H₂S) donor, shows potent anti-hepatocellular carcinoma activity through blocking the STAT3 pathway | Q39023096 | ||
GYY4137, a novel hydrogen sulfide-releasing molecule, likely protects against high glucose-induced cytotoxicity by activation of the AMPK/mTOR signal pathway in H9c2 cells. | Q39038826 | ||
Differential susceptibility to hydrogen sulfide-induced apoptosis between PHLDA1-overexpressing oral cancer cell lines and oral keratinocytes: role of PHLDA1 as an apoptosis suppressor | Q39056593 | ||
NOSH-aspirin (NBS-1120), a novel nitric oxide and hydrogen sulfide releasing hybrid, attenuates neuroinflammation induced by microglial and astrocytic activation: a new candidate for treatment of neurodegenerative disorders | Q39114886 | ||
Regulation of cystathionine γ-lyase in mammalian cells by hypoxia | Q39126123 | ||
Intramitochondrial hydrogen sulfide production by 3-mercaptopyruvate sulfurtransferase maintains mitochondrial electron flow and supports cellular bioenergetics | Q39252442 | ||
A New Hope for a Devastating Disease: Hydrogen Sulfide in Parkinson's Disease. | Q39325806 | ||
Signaling by sulfur-containing molecules. Quantitative aspects | Q39349439 | ||
Sp1 is involved in regulation of cystathionine γ-lyase gene expression and biological function by PI3K/Akt pathway in human hepatocellular carcinoma cell lines | Q39391366 | ||
Characterization of hydrogen sulfide and its synthases, cystathionine β-synthase and cystathionine γ-lyase, in human prostatic tissue and cells | Q39400649 | ||
Hydrogen sulfide-releasing NSAIDs inhibit the growth of human cancer cells: a general property and evidence of a tissue type-independent effect | Q39416914 | ||
Hydrogen sulfide and L-cysteine increase phosphatidylinositol 3,4,5-trisphosphate (PIP3) and glucose utilization by inhibiting phosphatase and tensin homolog (PTEN) protein and activating phosphoinositide 3-kinase (PI3K)/serine/threonine protein kin | Q35562685 | ||
Exogenous hydrogen sulfide exerts proliferation/anti-apoptosis/angiogenesis/migration effects via amplifying the activation of NF-κB pathway in PLC/PRF/5 hepatoma cells | Q35571393 | ||
Hydrogen sulfide as endothelium-derived hyperpolarizing factor sulfhydrates potassium channels | Q35603720 | ||
Specificity and some other properties of liver serine sulphhydrase: Evidence for its identity with cystathionine β-synthase | Q44954650 | ||
Hydrogen sulfide-induced apoptosis of human aorta smooth muscle cells via the activation of mitogen-activated protein kinases and caspase-3. | Q45061684 | ||
Reaction-based fluorescent probes for selective imaging of hydrogen sulfide in living cells | Q45232759 | ||
Dysregulated pH: a perfect storm for cancer progression. | Q45255109 | ||
Anti-apoptotic action of hydrogen sulfide is associated with early JNK inhibition. | Q45925801 | ||
Hydrogen sulfide protects against cellular senescence via S-sulfhydration of Keap1 and activation of Nrf2. | Q45947130 | ||
S-propargyl-cysteine protects both adult rat hearts and neonatal cardiomyocytes from ischemia/hypoxia injury: the contribution of the hydrogen sulfide-mediated pathway. | Q45957950 | ||
Hydrogen sulfide from adipose tissue is a novel insulin resistance regulator | Q46149486 | ||
Cystathionine beta-synthase as a carbon monoxide-sensitive regulator of bile excretion | Q46196479 | ||
Whole tissue hydrogen sulfide concentrations are orders of magnitude lower than presently accepted values | Q46361411 | ||
Hydrogen sulfide increases nitric oxide production with calcium-dependent activation of endothelial nitric oxide synthase in endothelial cells | Q46364517 | ||
Generation of endogenous hydrogen sulfide by cystathionine gamma-lyase limits renal ischemia/reperfusion injury and dysfunction | Q46446506 | ||
Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced inflammation in the mouse | Q46465914 | ||
Streptozotocin-induced diabetes in the rat is associated with enhanced tissue hydrogen sulfide biosynthesis | Q46557223 | ||
Hydrogen sulfide protects rat lung from ischemia-reperfusion injury | Q46593773 | ||
The possible role of hydrogen sulfide as an endogenous neuromodulator. | Q46606180 | ||
Characterization of a novel, water-soluble hydrogen sulfide-releasing molecule (GYY4137): new insights into the biology of hydrogen sulfide | Q46621665 | ||
Direct stimulation of K(ATP) channels by exogenous and endogenous hydrogen sulfide in vascular smooth muscle cells | Q46693585 | ||
High-throughput tandem-microwell assay identifies inhibitors of the hydrogen sulfide signaling pathway | Q46699363 | ||
Evidence that hydrogen sulfide exerts antinociceptive effects in the gastrointestinal tract by activating KATP channels | Q46726610 | ||
The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. | Q46738154 | ||
H2S: a universal defense against antibiotics in bacteria | Q46754342 | ||
Exogenous hydrogen sulfide (H2S) protects against regional myocardial ischemia-reperfusion injury--Evidence for a role of K ATP channels | Q46835777 | ||
Hydrogen sulfide contributes to cardioprotection during ischemia-reperfusion injury by opening K ATP channels | Q46861147 | ||
Renal protective effect of hydrogen sulfide in cisplatin-induced nephrotoxicity | Q47216689 | ||
The role of hydrogen sulfide in cyclic nucleotide signaling. | Q47381905 | ||
Chemical Biology of H2S Signaling through Persulfidation | Q47430972 | ||
Hydrogen sulfide attenuates neuronal injury induced by vascular dementia via inhibiting apoptosis in rats | Q47673598 | ||
Inhibition of respiratory and bioenergetic mechanisms by hydrogen sulfide in mammalian brain | Q47854783 | ||
H2S-induced S-sulfhydration of lactate dehydrogenase a (LDHA) stimulates cellular bioenergetics in HCT116 colon cancer cells | Q47921367 | ||
Exogenous hydrogen sulfide protects against global cerebral ischemia/reperfusion injury via its anti-oxidative, anti-inflammatory and anti-apoptotic effects in rats | Q48309111 | ||
Is development of high-grade gliomas sulfur-dependent? | Q48403130 | ||
Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer | Q49057404 | ||
Free and Acid-Labile Hydrogen Sulfide Concentrations in Mouse Tissues: Anomalously High Free Hydrogen Sulfide in Aortic Tissue | Q49057479 | ||
Renal protective effect of polysulfide in cisplatin-induced nephrotoxicity. | Q50136697 | ||
Garlic-derived S-allylmercaptocysteine is a novel in vivo antimetastatic agent for androgen-independent prostate cancer. | Q50693362 | ||
Dysregulation of hydrogen sulfide producing enzyme cystathionine γ-lyase contributes to maternal hypertension and placental abnormalities in preeclampsia. | Q50963577 | ||
Hydrogen sulfide and its possible roles in myocardial ischemia in experimental rats. | Q51119493 | ||
Spontaneous and Selective Formation of HSNO, a Crucial Intermediate Linking H2S and Nitroso Chemistries. | Q51192616 | ||
Atorvastatin affects the tissue concentration of hydrogen sulfide in mouse kidneys and other organs. | Q51486220 | ||
Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melbourne Colorectal Cancer Study. | Q52426535 | ||
Hydrogen sulfide (H2S)/cystathionine γ-lyase (CSE) pathway contributes to the proliferation of hepatoma cells. | Q52648729 | ||
HORMESIS: A Fundamental Concept with Widespread Biological and Biomedical Applications. | Q52665131 | ||
The multifaceted roles of nitric oxide in cancer. | Q53433015 | ||
Hydrogen sulfide improves glucose metabolism and prevents hypertrophy in cardiomyocytes. | Q53664011 | ||
Hydrogen sulfide promotes nitric oxide production in corpus cavernosum by enhancing expression of endothelial nitric oxide synthase. | Q54282706 | ||
The expression and activity of cystathionine-γ-lyase and 3-mercaptopyruvate sulfurtransferase in human neoplastic cell lines. | Q54429511 | ||
Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway. | Q55066553 | ||
P433 | issue | 1 | |
P304 | page(s) | 1-38 | |
P577 | publication date | 2018-06-29 | |
P1433 | published in | Antioxidants & Redox Signaling | Q4775078 |
P1476 | title | A Review of Hydrogen Sulfide Synthesis, Metabolism, and Measurement: Is Modulation of Hydrogen Sulfide a Novel Therapeutic for Cancer? | |
P478 | volume | 31 |
Q90285254 | Activatable Small-Molecule Hydrogen Sulfide Donors |
Q99727736 | Bioenergetic effects of hydrogen sulfide suppress soluble Flt-1 and soluble endoglin in cystathionine gamma-lyase compromised endothelial cells |
Q97544179 | Cystathionine gamma lyase and hydrogen sulfide: new players in orthodontic root resorption |
Q102323905 | Cysteine metabolic circuitries: druggable targets in cancer |
Q90472024 | Design, Validation, and Application of an Enzyme-Coupled Hydrogen Sulfide Detection Assay |
Q64237343 | Dual-biomarker-triggered fluorescence probes for differentiating cancer cells and revealing synergistic antioxidant effects under oxidative stress |
Q89634255 | Effect of S-Allyl -L-Cysteine on MCF-7 Cell Line 3-Mercaptopyruvate Sulfurtransferase/Sulfane Sulfur System, Viability and Apoptosis |
Q90746416 | Ellagic acid-Fe@BSA nanoparticles for endogenous H2S accelerated Fe(III)/Fe(II) conversion and photothermal synergistically enhanced chemodynamic therapy |
Q92523011 | Exogenous hydrogen sulfide alleviates surgery-induced neuroinflammatory cognitive impairment in adult mice by inhibiting NO signaling |
Q98280937 | HNF4α regulates sulfur amino acid metabolism and confers sensitivity to methionine restriction in liver cancer |
Q92860000 | Hydrogen Gas in Cancer Treatment |
Q90043601 | Hydrogen Sulfide Metabolism and Signaling in the Tumor Microenvironment |
Q64242163 | Hydrogen Sulfide Oxidation: Adaptive Changes in Mitochondria of SW480 Colorectal Cancer Cells upon Exposure to Hypoxia |
Q89834610 | Hydrogen Sulfide in Pharmacotherapy, Beyond the Hydrogen Sulfide-Donors |
Q64078914 | Hydrogen sulfide inhibits PCSK9 expression through the PI3K/Akt‑SREBP‑2 signaling pathway to influence lipid metabolism in HepG2 cells |
Q92423074 | N-Acetylcysteine Serves as Substrate of 3-Mercaptopyruvate Sulfurtransferase and Stimulates Sulfide Metabolism in Colon Cancer Cells |
Q89636116 | Opposing effects of polysulfides and thioredoxin on apoptosis through caspase persulfidation |
Q61818125 | Protective Smell of Hydrogen Sulfide and Polysulfide in Cisplatin-Induced Nephrotoxicity |
Q90043563 | Recycling the Interspecific Relations with Epithelial Cells: Bacteria and Cancer Metabolic Symbiosis |
Q93075306 | S-nitrosothiols and H2S donors: Potential chemo-therapeutic agents in cancer |
Search more.